Human and mammalian stem cell-derived neuron survival factors
US7273725B2 · kind B2 · utility
0Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 22, 2002 |
| Grant date | Sep 25, 2007 |
| Priority date | — |
| Expiry date | Oct 22, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to human, rat and mouse stem cell-derived neuron survival factor polypeptides (SDNSF), a process for producing them, cDNA encoding SDNSF, a vector comprising the cDNA, host cells transformed by the vector, an antibody against SDNSF, pharmaceutical compositions containing SDNSF or the antibody, a method of assaying SDNSF, a reagent for assaying SDNSF, and a screening method using SDNSF. The polypeptides are effective in the survival of nerve cells and, therefore, efficacious in treating injury to the central nerve system caused by brain infarction, brain hemorrhage, spinal cord injury, etc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.